Immunoglobulin G4 and Immunoglobulin E Antibodies in a Population With Adverse Reactions to Foodstuffs-related Symptoms
Launched by UNIVERSIDAD POLITECNICA DE MADRID · Jan 3, 2023
Trial Information
Current as of June 28, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how certain antibodies in the body, specifically Immunoglobulin G4 (IgG4) and Immunoglobulin E (IgE), relate to symptoms that people experience when they have adverse reactions to foods. The researchers want to understand the levels of these antibodies in individuals who have symptoms linked to food allergies or other food-related reactions.
If you are an adult over 18 years old and have experienced symptoms related to these food reactions, you may be eligible to participate in this study. However, if you are currently undergoing antibiotic treatment, you won't be able to join. Participants in the trial will help researchers gather important information that could improve our understanding of food allergies and related conditions. The study is currently looking for volunteers, so if you or someone you know fits the criteria, it could be a valuable opportunity to contribute to this important research.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults (\>18 years of age)
- • To present symptoms related to adverse reactions to foodstuffs (ARFS)
- Exclusion Criteria:
- • Antibiotic treatment
About Universidad Politecnica De Madrid
The Universidad Politécnica de Madrid (UPM) is a leading institution in engineering and technology education, renowned for its commitment to innovation and research excellence. As a clinical trial sponsor, UPM leverages its interdisciplinary expertise to advance medical research and develop novel therapeutic solutions. The university fosters collaborations with healthcare professionals, industry partners, and research organizations to conduct rigorous clinical studies that aim to improve patient outcomes and contribute to the scientific community. With a strong emphasis on ethical practices and regulatory compliance, UPM is dedicated to enhancing the landscape of clinical research through its robust academic framework and cutting-edge facilities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madrid, , Spain
Patients applied
Trial Officials
Lisset Pantoja-Arévalo, MSc
Principal Investigator
Universidad Politecnica de Madrid
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials